On May 17, 2022 Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates," or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineered toxin bodies (ETBs), reported that it will participate in the following upcoming investor conferences (Press release, Molecular Templates, MAY 17, 2022, View Source [SID1234614812]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details can be found below:

H.C. Wainwright Global Investment Conference (May 23-26, 2022)
Location: Virtual
Format:

Date: Company Presentation

Tuesday, May 24th
Time: 7:00 AM ET

Jefferies Healthcare Conference (June 8-10, 2022)
Location: Marriott Marquis in New York, New York
Format:

Date: Fireside Chat

Thursday, June 9th
Time: 2:00 PM – 2:25 PM ET
Webcast links for the presentations will be posted on the "News & Media" section of the Molecular Templates corporate website, under Events.